高级检索
当前位置: 首页 > 详情页

Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

单位: [1]Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease [2]Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease [3]The Sixth People`s Hospital of Zhengzhou [4]The Second Hospital of Nanjing [5]Shenyang Sixth People`s Hospital [6]Guangzhou Eighth People’s Hospital [7]Department of Infectious Diseases, Southwest Hospital, Third Military Medical University [8]Qingdao Municipal Hospital [9]Jinan City Infectious Diseases Hospital [10]Sixth People’s Hospital of Dalian [11]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China [12]First Hospital of Jilin University [13]Beijing Youan Hospital, Capital Medical University [14]Affiliated Hospital of Yanbian [15]Beijing Kawin Technology Share-Holding Co., Ltd [16]Peking University Hepatology Institute, Peking University People’s Hospital
出处:
ISSN:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
JCR分区:
出版当年[2016]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2016版] 出版当年五年平均[2012-2016] 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Peking University People’s Hospital, Peking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver Disease
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)